---
title: "派傑繼續維持對 Immuneering（IMRX）的買入評級"
description: "Bratzel 涉及醫療保健行業，關注的股票包括 Abivax SA Sponsored ADR、Argenx Se 和 Ardelyx。根據 TipRanks 的數據，Bratzel 的平均回報率為 52.0%，推薦股票的成功率為 68.52%。目前，分析師對 Immuneering 的共識評級為強烈買入，平均目標價為 15.20 美元，意味着從當前水平有 90.00% 的上漲空間。在昨天發佈的"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/259041359.md"
published_at: "2025-09-26T10:37:13.000Z"
---

# 派傑繼續維持對 Immuneering（IMRX）的買入評級

> Bratzel 涉及醫療保健行業，關注的股票包括 Abivax SA Sponsored ADR、Argenx Se 和 Ardelyx。根據 TipRanks 的數據，Bratzel 的平均回報率為 52.0%，推薦股票的成功率為 68.52%。目前，分析師對 Immuneering 的共識評級為強烈買入，平均目標價為 15.20 美元，意味着從當前水平有 90.00% 的上漲空間。在昨天發佈的一份報告中，瑞穗證券也維持了該股票的買入評級，目標價為 10.00 美元

Bratzel 涉及醫療保健行業，關注的股票包括 Abivax SA Sponsored ADR、Argenx Se 和 Ardelyx。根據 TipRanks 的數據，Bratzel 推薦股票的平均回報率為 52.0%，成功率為 68.52%。

目前，分析師對 Immuneering 的共識評級為強烈買入，平均目標價為 15.20 美元，意味着從當前水平有 90.00% 的上漲空間。在昨天發佈的一份報告中，瑞穗證券也維持了該股票的買入評級，目標價為 10.00 美元。

### Related Stocks

- [IMRX.US - Immuneering](https://longbridge.com/zh-HK/quote/IMRX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Immuneering Director Thomas J. Schall Reports Acquisition of Common Shares | Thomas J. Schall, Director of Immuneering Corporation, has reported the acquisition of Class A common shares of the comp | [Link](https://longbridge.com/zh-HK/news/273098166.md) |
| Top Immuneering Executive Makes Bold Move With Fresh Stock Purchase | Immuneering's Chief People Officer, Leah R. Neufeld, purchased 2,626 shares of the company's stock, valued at $10,897, i | [Link](https://longbridge.com/zh-HK/news/272771964.md) |
| Evercore ISI Sticks to Their Buy Rating for CVS Health (CVS) | Evercore ISI analyst Elizabeth Anderson maintained a Buy rating on CVS Health (CVS) with a price target of $100.00. Ande | [Link](https://longbridge.com/zh-HK/news/275622408.md) |
| Jorie AI Shares a Live Case Study on the Inevitable Future of Healthcare AI at ViVE 2026 | Jorie AI showcased its autonomous healthcare AI solutions at ViVE 2026, emphasizing the need for AI to operate effective | [Link](https://longbridge.com/zh-HK/news/275497445.md) |
| ZAWYA-PRESSR: Healthcare leaders call for greater strategic alignment between capital investment and health system strategy at WHX | Global healthcare leaders gathered at the World Health Expo (WHX) to discuss the need for strategic alignment between ca | [Link](https://longbridge.com/zh-HK/news/275449733.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。